JACC: Advances: Scope, Impact Factor, and Access

JACC: Advances is a peer-reviewed, open-access scholarly journal launched in 2022 as part of the Journal of the American College of Cardiology (JACC) family. Published in partnership between the American College of Cardiology (ACC) and Elsevier, the journal serves as a dedicated platform for emerging subspecialties, multidisciplinary care models, and clinical innovations across cardiovascular medicine.

What it is

JACC: Advances is an international, electronic-only medical journal (eISSN 2772-963X, NLM Unique ID 9918419284106676) that operates under a fully Gold open-access publishing model. Unlike subscription-based specialty periodicals that place newly published clinical trials behind institutional paywalls, all articles in JACC: Advances are made freely accessible online immediately upon release.

The journal was established to address an evolving gap in the cardiovascular literature. As clinical cardiology has matured, patient demographics and therapeutic technologies have shifted dramatically. Subspecialty intersections—such as cardiovascular care in pregnant patients, multidisciplinary critical care in modern intensive coronary units, and the lifelong management of adults born with congenital heart defects—frequently span across conventional departmental boundaries. JACC: Advances was created to provide a high-visibility, rigorous home for clinical investigations, state-of-the-art reviews, research letters, and multidisciplinary viewpoints that illuminate these paradigm shifts.

Key bibliographic identifiers cataloged by the National Library of Medicine (NLM) include:

• Electronic ISSN (eISSN): 2772-963X
• NLM Title Abbreviation: JACC Adv
• NLM Unique ID: 9918419284106676
• First Volume and Year: Volume 1, Issue 1 (March 2022)
• Publishing Entity: Elsevier Inc. (New York) on behalf of the American College of Cardiology Foundation
• Official Indexing: PubMed, PubMed Central (PMC), Scopus, and the Emerging Sources Citation Index (ESCI) in the Web of Science Core Collection
• Official Metric: Inaugural Journal Impact Factor of 5.5, announced in Clarivate Journal Citation Reports (JCR)

Who runs it and what it covers

Editorial leadership of JACC: Advances is headed by inaugural Editor-in-Chief Dr. Candice K. Silversides, MD, FRCPC, a specialist in adult congenital heart disease and cardio-obstetrics and Professor of Medicine at the University of Toronto. Editorial direction is governed by the American College of Cardiology Foundation, ensuring adherence to the same rigorous editorial benchmarks and peer-review process maintained across the JACC journal portfolio. Elsevier manages digital production, online hosting via ScienceDirect, and worldwide dissemination.

The journal’s editorial remit spans emerging, multidisciplinary, and under-represented areas within cardiovascular health, including:

• Cardio-Obstetrics: Preconception risk stratification, maternal hemodynamics, management of hypertensive disorders of pregnancy, and cardiovascular complications during gestation and postpartum.
• Adult Congenital Heart Disease (ACHD): Long-term outcomes, structural interventions, rhythm disorders, and systemic sequelae in adults who underwent pediatric surgical repairs.
• Geriatric Cardiology: Multimorbidity management, frailty assessment, polypharmacy interactions, and individualized decision-making in older adults with complex cardiovascular disease.
• Critical Care Cardiology: Hemodynamic monitoring, mechanical circulatory support, cardiogenic shock management, and contemporary intensive cardiac care unit protocols.
• Neurocardiology: Integrated mechanisms linking cardiac pathologies and brain health, including stroke prevention, vascular cognitive impairment, and autonomic dysregulation.
• Pediatric Cardiovascular Health: Cardiometabolic risk factor prevention, pediatric heart failure, and early-life interventions.
• Technological and Methodological Advances: Clinical artificial intelligence, machine learning algorithms, digital health applications, and novel investigative imaging techniques.
• Established Specialties: Significant translational and clinical developments in interventional cardiology, electrophysiology, and heart failure that offer fresh therapeutic frameworks.

How to search or use it

Cardiovascular clinicians, researchers, and information specialists interact with JACC: Advances as both readers and authors through Elsevier and JACC online interfaces. Below is the operational workflow for searching contents and preparing submissions:

1. Access the Journal Portal: Navigate to the official JACC: Advances journal homepage on the JACC website (jacc.org/journal/advances) or the ScienceDirect platform.
2. Search Articles and Collections: Use the search field at the top of the interface to locate manuscripts by keyword, topic, author name, or Digital Object Identifier (DOI). Results can be filtered by publication date, article type (e.g., Original Research, Review Article, Research Letter), or thematic focus issue.
3. Review Central Illustrations: Each major research paper includes an editorially vetted “Central Illustration” developed with certified medical illustrators, designed to summarize the clinical trial design, key hemodynamic findings, or diagnostic algorithm at a single glance.
4. Verify Author Guidelines: Prospective contributors should consult the official “Guide for Authors” on ScienceDirect before preparing a manuscript, verifying word limits, reference styles, structured abstract formats, and required conflict of interest disclosures.
5. Submit via Editorial Manager: Click the “Submit Your Paper” link on the journal portal, which redirects to the Editorial Manager manuscript tracking system. Log in using your existing account or register a new user profile linked to your ORCID iD.
6. Select Submission Route: Authors submit original research directly or opt into the JACC family transfer system. Manuscripts reviewed by the flagship JACC or companion specialty journals that receive positive reviews but lack space can be seamlessly transferred to JACC: Advances along with existing reviewer evaluations.
7. Complete Open Access and APC Formalities: Upon manuscript acceptance, authors choose their Creative Commons licensing terms (standard CC BY-NC-ND or CC BY for eligible funder policies) and process the requisite article processing charges (APCs) or verify institutional transformation agreements.

Strengths and limits

Evaluating JACC: Advances requires balancing its editorial prestige against its operational profile:

• Strengths:
  • High Editorial Authority: Direct backing from the American College of Cardiology provides immediate international clinical credibility and editorial consistency.
  • Rapid Dissemination: Continuous, article-based publishing ensures accepted papers are issued a citable DOI and deposited into PubMed Central without waiting for scheduled issue closings.
  • Niche Subspecialty Visibility: Provides a dedicated mainstream forum for fields like cardio-obstetrics, ACHD, and critical care cardiology that previously had limited targeted journal space.
  • Established Citation Performance: Earning an inaugural Journal Impact Factor of 5.5 places the journal competitively among contemporary general and specialized cardiovascular publications.
• Limits:
  • Author-Facing Publishing Fees: As a Gold open-access title, authors without institutional waivers or funder grant backing must pay an article processing charge to publish.
  • Emerging Archival Track Record: Begun in 2022, its historical backfile is younger than century-old legacy titles, meaning longitudinal citation dynamics are still developing.
  • Electronic-Only Distribution: The journal does not issue physical print volumes, relying entirely on digital readers and institutional repository indexing.

Alternatives

Researchers deciding where to read or submit cardiovascular work have multiple peer-reviewed outlets within and outside the American College of Cardiology portfolio:

Journal	Publishing Model	Primary Focus	Editorial Organization
JACC: Advances	Gold Open Access	Emerging cardiovascular subspecialties, multidisciplinary care, cardio-obstetrics, geriatric and critical care cardiology	American College of Cardiology / Elsevier
Journal of the American College of Cardiology (JACC)	Hybrid Open Access	Broad, high-impact clinical cardiology trials, large randomized studies, practice guidelines	American College of Cardiology / Elsevier
JACC: Basic to Translational Science	Gold Open Access	Preclinical models, translational cardiovascular biology, and early-phase experimental therapeutics	American College of Cardiology / Elsevier
JACC: Case Reports	Gold Open Access	Clinical case studies, unexpected educational presentations, and clinical problem-solving	American College of Cardiology / Elsevier
Circulation: Genomic and Precision Medicine	Hybrid Open Access	Cardiovascular genetics, precision phenotyping, biomarkers, and personalized therapeutics	American Heart Association / Wolters Kluwer

FAQ

Is JACC: Advances indexed in PubMed?

Yes. JACC: Advances is indexed in PubMed and archived in PubMed Central (PMC). Citations and full-text articles can be discovered directly via the National Library of Medicine databases using the NLM abbreviation JACC Adv or eISSN 2772-963X.

What is the Journal Impact Factor of JACC: Advances?

JACC: Advances received an inaugural Journal Impact Factor of 5.5 in Clarivate’s Journal Citation Reports. Researchers can confirm updated bibliometrics following standard methodologies on how to look up a journal’s impact factor.

Who is the Editor-in-Chief of JACC: Advances?

The inaugural Editor-in-Chief is Dr. Candice K. Silversides, MD, FRCPC, a professor of medicine at the University of Toronto with clinical expertise in adult congenital heart disease and cardio-obstetrics.

Does JACC: Advances charge publication fees?

Because JACC: Advances is a Gold open-access journal, accepted papers are subject to an article processing charge (APC) to cover peer-review administration, technical editing, and permanent open hosting, unless discounted or waived under institutional agreements or society affiliations.

Sources

• National Library of Medicine. NLM Catalog: JACC. Advances (NLM Unique ID: 9918419284106676; eISSN 2772-963X). Checked 2026-11-07. https://www.ncbi.nlm.nih.gov/nlmcatalog/9918419284106676
• Silversides CK. JACC: Advances and the Future of Cardiology. JACC Adv. 2022 Mar; 1(1): 100001. doi: 10.1016/j.jacadv.2022.100001. PMCID: PMC11198452. Checked 2026-11-07. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11198452/
• American College of Cardiology. Candice Silversides Named Editor-in-Chief of JACC: Advances. Official ACC News Release. Checked 2026-11-07. https://www.acc.org/latest-in-cardiology/articles/2021/10/26/18/43/candice-silversides-named-editor-in-chief-of-jacc-advances
• Elsevier. Guide for Authors: JACC: Advances (ISSN 2772-963X). ScienceDirect Publication Portal. Checked 2026-11-07. https://www.sciencedirect.com/journal/jacc-advances